Q2 2026 Imunon Inc Earnings Call Transcript
Good morning I will be your conference operator for today. At this time, I would like to welcome everyone to the IMUNON second-quarter 2026 financial results and business update conference call. I will now turn the call over to Valter Pinto, Managing Director of Investor Relations at KCSA Strategic Communications for introductions. Please go ahead.
Thank you, operator, and good morning. Welcome to IMUNON second-quarter 2026 financial results and business update conference call. Joining us today are Stacy Lindborg, President and Chief Executive Officer; Dr. Douglas Faller, Chief Medical Officer; and Josh Blacher, Chief Financial Officer. Michael Tardugno, the company's Executive Chairman, is also in the line for the Q&A portion of today's call.
Before we begin, I'd like to remind everyone that our remarks today include forward-looking statements. These statements are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
